Copyright
©2013 Baishideng Publishing Group Co., Limited. All rights reserved.
World J Gastrointest Oncol. Jul 15, 2013; 5(7): 113-114
Published online Jul 15, 2013. doi: 10.4251/wjgo.v5.i7.113
Published online Jul 15, 2013. doi: 10.4251/wjgo.v5.i7.113
Hilar cholangiocarcinoma
José M Ramia, Department of Surgery, Hospital Universitario de Guadalajara, 19002 Guadalajara, Spain
Author contributions: Ramia JM solely contributed to this paper.
Correspondence to: José M Ramia, MD, PhD, Department of Surgery, Hospital Universitario de Guadalajara, Donante de Sangre, S/N, 19002 Guadalajara, Spain. jose_ramia@hotmail.com
Telephone: +34-61-6292056 Fax: +34-94-9209218
Received: March 11, 2013
Revised: June 16, 2013
Accepted: July 4, 2013
Published online: July 15, 2013
Processing time: 141 Days and 18.7 Hours
Revised: June 16, 2013
Accepted: July 4, 2013
Published online: July 15, 2013
Processing time: 141 Days and 18.7 Hours
Core Tip
Core tip: Most remarked avances are: imaging methods have improved diagnostic sensitivity and specificity, especially for determining biliary and vascular involvement; there have been several proposals to improve the classic Bismuth-Corlette classification; pre- and post-operative care; technical aspects trying to obtain a R0 resection: widespread use of liver resection, resection of segment I and venous and arterial resection, refinement of post-operative histology and adjuvant therapies.